1873 — VIVA Biotech Holdings Share News
0.000.00%
Last trade - 00:00- HK$2.68bn
- HK$2.54bn
- CNY1.73bn
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical
Brief: Viva Biotech Holdings Expects Net Profit Of RMB210 Million To RMB240 Million For 2024
Brief: VIVA Biotech Says Resolved To Repurchase Shares Of Company For Up To HK$100 Million
Brief: VIVA Biotech Holdings Posts H1 Revenue Of RMB981.8 Mln
Investment
Brief: Viva Biotech Says Disposal Of Equity Interest In A Subsidiary
Chief Financial Officer
Brief: Viva Biotech Secures Approximately US $210 Million Funding
Brief: Viva Biotech Says As Of Oct 13, Repurchased Aggregate Principal Amount Of $43 Mln Of Convertible Bonds
Brief: Viva Biotech Announces Entered Equity Transfer Agreement
Brief: Viva Biotech Posts HY Adjusted Non-IFRS Net Profit Rmb146.1 Million
Brief: Viva Biotech Sees Revenue To Reach RMB1,138 Mln For HY
Brief: Viva Biotech's Portfolio Company DTX Pharma Says Reached Acquisition Agreement With Novartis
Deals of the day-Mergers and acquisitions
Deals of the day-Mergers and acquisitions
Temasek-backed firms buy stake in VIVA Biotech unit ahead of listing (updated)